Teh‐Fu Hsu

ORCID: 0000-0001-7235-4754 · 5 papers in corpus
article 2022
Maintenance dienogest therapy following adjuvant gonadotropin-releasing hormone agonist treatment after uterus-sparing surgery in adenomyosis: A retrospective cohort study
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.14635

OBJECTIVE: To investigate the safety and efficacy of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) treatment followed by maintenance dienogest (DNG) therapy after uterus-sparing surgery. METHODS: Retrospective cohort study. A to…

article 2022
Maintenance Therapy for Preventing Endometrioma Recurrence After Endometriosis Resection Surgery—A Systematic Review and Network Meta-analysis
·doi:10.1097/ogx.0000000000001045

(Abstracted from J Minim Invasive Gynecol 2022;29:602–612) Endometriosis is one of the most common gynecologic disorders, affecting approximately 10% of reproductive-age women and presenting with dysmenorrhea, noncyclic pelvic pain, dyspare…

article 2018
Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2017.12.036

OBJECTIVE: To evaluate whether a maintenance levonorgestrel-releasing intrauterine system is effective for preventing the recurrence of postoperative adenomyosis-related symptoms. MATERIALS AND METHODS: From January 2005 through December 20…

article 2017
Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2017.02.008

BackgroundAccording to 3 randomized trials, the levonorgestrel-releasing intrauterine system significantly reduced recurrent endometriosis-related pelvic pain at postoperative year 1. Only a few studies have evaluated the long-term effectiv…

letter 2017
Reply
·doi:10.1016/j.ajog.2017.08.014